K.GaryVanasseMD

Assistant Professor of Medicine, Brigham and Women's Hospital

Are you Dr. Vanasse?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 85 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Dr. K. Vanasse, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Dana-Farber Cancer Institute and Westerly Hospital.

University of WashingtonFellowship, Hematology and Medical Oncology, 1996 - 1998
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1992 - 1995
Georgetown University School of MedicineClass of 1992

PubMed

40 citations
The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma
Marc S. Raab, Sheeba K. Thomas, Enrique M. Ocio, Andreas Guenther, Yeow Tee Goh, Moshe Talpaz, Nicolas Hohmann, Sylvia Zhao, Fang Xiang, Carl Simon, K. Gary Vanasse, S...> ;Leukemia. 2019 Dec 1
324 citations
The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1
Andrew Wylie, Joseph Schoepfer, Wolfgang Jahnke, Sandra W. Cowan-Jacob, Alice Loo, Pascal Furet, Andreas Marzinzik, Xavier Pelle, Jerry Donovan, Wenjing Zhu, Silvia Bu...> ;Nature. 2017 Mar 30
56 citations
Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Inser...
Matthew Burger, Gisele Nishiguchi, Wooseok Han, Jiong Lan, Robert Lowell Simmons, Gordana Atallah, Yu Ding, Victoriano Tamez, Zhang Yanchen, Michelle Mathur, Kristine ...> ;Journal of Medicinal Chemistry. 2015 Oct 27